PMID: 5884654Sep 18, 1965Paper

Blood levels of drug at the equilibrium state after multiple dosing

Nature
J G WagnerO S Carpenter

Abstract

No abstract listed.

References

Oct 1, 1958·Journal of the American Pharmaceutical Association·J V SWINTOSKYM J ROBINSON
Jan 1, 1961·The Journal of Clinical Investigation·J F TAITK R LAUMAS
Jun 1, 1963·Journal of Pharmaceutical Sciences·J G WAGNER, E NELSON
Mar 1, 1963·Journal of Pharmaceutical Sciences·R G WIEGANDC J ENDICOTT
Feb 1, 1962·Klinische Wochenschrift·E KRUEGER-THIEMER
Nov 1, 1945·Proceedings of the Society for Experimental Biology and Medicine·R DOMINGUEZ, E POMERENE

❮ Previous
Next ❯

Citations

Mar 1, 1968·The Journal of Clinical Pharmacology and the Journal of New Drugs·J G Wagner, R E Damiano
Oct 1, 1974·Journal of Clinical Pharmacology·R G StollA R DiSanto
Nov 1, 1976·Journal of Clinical Pharmacology·M F Paulson, P G Welling
Mar 20, 1998·Journal of Clinical Pharmacology·C M Swartz
Sep 24, 1975·Naunyn-Schmiedeberg's Archives of Pharmacology·A Nagy, R Johansson
Jan 1, 1983·European Journal of Clinical Pharmacology·I Janků
Jan 1, 1982·European Journal of Clinical Pharmacology·M EichelbaumG E von Unruh
Aug 23, 1974·European Journal of Clinical Pharmacology·M D RawlinsF Sjöqvist
Aug 23, 1974·European Journal of Clinical Pharmacology·J L Cunningham, D A Evans
Oct 4, 1974·European Journal of Clinical Pharmacology·G AlvánJ E Lindgren
Dec 1, 1978·European Journal of Clinical Pharmacology·J DickersonR Bressler
Jan 1, 1974·European Journal of Clinical Pharmacology·L LundB Alexanderson
Jul 1, 1980·European Journal of Clinical Pharmacology·H LagercrantzR Tunell
Feb 28, 1975·European Journal of Clinical Pharmacology·M D RawlinsL Palmér
Aug 1, 1980·European Journal of Clinical Pharmacology·U Bergman Ostman
Jan 1, 1980·European Journal of Clinical Pharmacology·G J SchapelP E Stanley
Feb 1, 1981·European Journal of Clinical Pharmacology·K LandmarkJ P Amlie
Jun 13, 1975·European Journal of Clinical Pharmacology·M EichelbaumA Rane
Jan 1, 1977·European Journal of Clinical Pharmacology·G Wettrell
Mar 17, 1978·European Journal of Clinical Pharmacology·R Gugler, G Bodem
Mar 17, 1978·European Journal of Clinical Pharmacology·R K ElwoodD G McDevitt
Mar 17, 1978·European Journal of Clinical Pharmacology·U KlotzW A Müller
Dec 2, 1977·European Journal of Clinical Pharmacology·J EkstrandA Norlin
Nov 14, 1977·European Journal of Clinical Pharmacology·P A RoutledgeM D Rawlins
Mar 26, 1979·European Journal of Clinical Pharmacology·N Heinz, N Rietbrock
Jan 1, 1975·European Journal of Clinical Pharmacology·E J TriggsJ J Ashley
Jan 1, 1981·European Journal of Clinical Pharmacology·P Anderson, H E Norbeck
Oct 14, 1977·European Journal of Clinical Pharmacology·R GuglerH U Schulz
Aug 1, 1977·Klinische Wochenschrift·E JähnchenH J Gilfrich
Nov 15, 1985·Klinische Wochenschrift·C ZekornM Eichelbaum
Oct 1, 1992·Environmental Geochemistry and Health·W R Chappell
Jan 1, 1987·European Journal of Clinical Pharmacology·R J DobbsS M Dobbs
Jan 1, 1981·Pharmacology & Therapeutics·J G Wagner
Apr 1, 1981·Psychiatry Research·H J de CuyperR A de Zeeuw
Aug 1, 1983·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·A G Rauws

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.